Home Reports Hematopoietic Stem Cell Transplantation Market

Hematopoietic Stem Cell Transplantation Market

Hematopoietic Stem Cell Transplantation Market is segmented by Transplant Type (Allogeneic, Autologous), Indication (Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, Other Non-Malignant Disorders), Application (Peripheral Blood Stem Cells Transplant, Bone Marrow Transplant, Cord Blood Transplant), and Region. Forecast for 2026 to 2036.

Methodology

Hematopoietic Stem Cell Transplantation Market Size, Market Forecast and Outlook By FMI

Summary of the Hematopoietic Stem Cell Transplantation Market

  • Demand and Growth Drivers
    • Indication expansion is increasing the patient population eligible for HSCT.
    • Donor source diversification is improving transplant accessibility.
    • Post-transplant outcome improvement is supporting broader clinical adoption.
  • Product and Segment View
    • Allogeneic transplants are expected to lead with 57.3% of transplant type demand in 2026.
    • Acute myeloid leukemia is expected to represent 38.5% of indication demand.
    • Peripheral blood stem cell transplants are expected to account for 47.6% of application demand.
  • Geography and Competitive Outlook
    • South Korea (8.0%) and the EU (7.9%) are expected to lead growth.
    • The USA (7.7%) maintains growth through the highest global transplant volume.
    • Companies with cell therapy portfolios and transplant support products are expected to capture growth in the expanding transplant market.
  • Analyst Opinion
    • The HSCT market is sustained by expanding clinical indications and improving transplant outcomes that support broader adoption.
    • Allogeneic transplantation growth is driven by donor source diversification and haploidentical transplant technique advancement.
    • The market is benefiting from improved GVHD management and supportive care that reduce transplant-related mortality.
    • Companies supporting the transplant pathway from cell processing through post-transplant complication management are expected to capture integrated value.

Hematopoietic Stem Cell Transplantation Market Value Analysis

Hematopoietic Stem Cell Transplantation Market Definition

The hematopoietic stem cell transplantation market covers clinical services, pharmaceutical products, and supportive care associated with bone marrow and stem cell transplantation procedures for hematological malignancies, bone marrow failure syndromes, and immune deficiency conditions. Services include donor matching, conditioning regimens, transplantation procedures, and post-transplant management.

Hematopoietic Stem Cell Transplantation Market Inclusions

Market scope covers all commercially delivered HSCT services categorized by transplant type (allogeneic, autologous), indication (acute myeloid leukemia, lymphoma, multiple myeloma, aplastic anemia, others), application (peripheral blood stem cells transplant, bone marrow transplant, cord blood transplant), and end user (transplant centres, hospitals, specialty centres). Revenue coverage spans 2026 to 2036.

Hematopoietic Stem Cell Transplantation Market Exclusions

The scope does not include CAR-T cell therapy, gene therapy, or general oncology treatments not directly associated with the transplantation procedure.

Hematopoietic Stem Cell Transplantation Market Research Methodology

  • Primary Research: FMI analysts conducted interviews with transplant physicians, transplant centre directors, and pharmaceutical procurement managers at hematopoietic stem cell transplant programmes.
  • Desk Research: Combined data from transplant activity registries, pharmaceutical sales databases, and transplant centre utilization records.
  • Market Sizing and Forecasting: Bottom-up sizing across transplant type, indication, and application segments with regional transplant activity curves.
  • Data Validation: Cross-checked quarterly against CIBMTR, EBMT, and regional transplant registry data, pharmaceutical sales volumes, and transplant centre activity reports.

Why is the Hematopoietic Stem Cell Transplantation Market Growing?

  • Expanding indication approvals and evolving conditioning regimens are increasing the number of patients eligible for hematopoietic stem cell transplantation across hematological malignancies and non-malignant conditions.
  • Growth in international donor registries and alternative donor sources including haploidentical and cord blood transplants is increasing donor availability and transplant accessibility.
  • Improving post-transplant supportive care including graft-versus-host disease prophylaxis is reducing transplant-related mortality and supporting broader clinical adoption.

Demand for hematopoietic stem cell transplantation reflects the expanding clinical indications, improving transplant outcomes, and growing accessibility of donor sources. HSCT remains the only curative treatment for many hematological malignancies and bone marrow failure syndromes, creating sustained demand proportional to disease incidence and transplant centre capacity.

Adoption of allogeneic transplantation leads at 57.3% of transplant type demand, reflecting the clinical preference for donor-sourced stem cells in indications where graft-versus-leukemia effect provides therapeutic benefit. Allogeneic transplants require donor matching and carry graft-versus-host disease risk, but offer superior relapse prevention in many hematological malignancies compared to autologous approaches.

Pricing reflects the comprehensive nature of HSCT, encompassing donor search and procurement, conditioning chemotherapy, the transplantation procedure itself, and extended post-transplant monitoring and supportive care. Total transplant episode costs vary significantly by transplant type, indication, and complication profile, with allogeneic transplants typically more expensive than autologous procedures.

Market Segmentation Analysis

  • Allogeneic accounts for 57.3% of the transplant type segment.
  • Acute Myeloid Leukemia represents 38.5% of the indication segment.
  • Peripheral Blood Stem Cells Transplant leads the application segment with 47.6% share.

The hematopoietic stem cell transplantation market is segmented by transplant type, indication, application source, and end user. Demand is driven by disease incidence, transplant centre capacity, donor availability, and the evolving clinical evidence supporting transplant across expanding indications.

Insights into the Allogeneic Transplant Type Segment

Hematopoietic Stem Cell Transplantation Market Analysis By Transplant Type

Allogeneic transplantation leads at 57.3% due to the clinical preference for donor-sourced stem cells that provide graft-versus-disease benefit in hematological malignancies. Expanding donor registries, haploidentical transplant techniques, and cord blood banking are increasing allogeneic donor availability.

Insights into the Acute Myeloid Leukemia Indication Segment

Hematopoietic Stem Cell Transplantation Market Analysis By Indication

Acute myeloid leukemia represents 38.5% of indication demand, reflecting its position as the most common indication for allogeneic HSCT. AML patients in first or second complete remission represent the largest single patient population referred for transplant evaluation.

Hematopoietic Stem Cell Transplantation Market Drivers, Restraints, and Opportunities

  • Regulatory and structural demand drivers are creating sustained procurement patterns.
  • Cost and access constraints create segmentation in adoption rates.
  • Technology and product development are expanding the addressable market.

The hematopoietic stem cell transplantation market is shaped by regulatory, technology, and procurement dynamics.

Indication Expansion

Demand is shaped by expanding clinical indications for HSCT beyond traditional acute leukemia to include myelodysplastic syndromes, myeloproliferative neoplasms, and non-malignant conditions including hemoglobinopathies and primary immunodeficiencies.

Donor Source Diversification

Growth reflects the increasing availability of alternative donor sources including haploidentical family donors, unrelated donors through international registries, and cord blood units that reduce the donor availability barrier.

Post-Transplant Outcome Improvement

Adoption is supported by improving GVHD prophylaxis, infection management, and supportive care protocols that reduce transplant-related mortality and improve long-term survival, supporting broader clinical adoption.

Transplant Centre Capacity Constraints

Transplant centre capacity, including bed availability, transplant physician workforce, and support team resources, constrains transplant volumes in some regions despite growing clinical demand.

Analysis of Hematopoietic Stem Cell Transplantation Market By Key Countries

Top Country Growth Comparison Hematopoietic Stem Cell Transplantation Market Cagr (2026 2036)

Country CAGR
South Korea 8.0%
EU 7.9%
Japan 7.8%
UK 7.7%
USA 7.6%

Hematopoietic Stem Cell Transplantation Market Cagr Analysis By Country

  • South Korea leads with 8.0% CAGR.
  • EU at 7.9% reflects expanding capabilities.
  • Japan (7.8%) and UK (7.7%) maintain steady growth.

The global hematopoietic stem cell transplantation market is expected to grow at 7.8% per year from 2026 to 2036.

Demand Outlook for Hematopoietic Stem Cell Transplantation Market in South Korea

South Korea is expected to grow at 8.0% through 2036, supported by expanding transplant centre capacity, growing donor registry participation, and advancing transplant technology adoption.

  • Transplant centre expansion increases procedure capacity.
  • Donor registry growth improves matching availability.
  • Technology advancement supports transplant outcomes.

Future Outlook for Hematopoietic Stem Cell Transplantation Market in the European Union

The EU is expected to grow at 7.9% through 2036, driven by EBMT-coordinated transplant activity, cross-border donor sharing, and comprehensive transplant centre infrastructure.

  • EBMT coordination supports cross-border collaboration.
  • Donor sharing programs optimize matching opportunities.
  • Transplant infrastructure provides comprehensive care.

In-depth Analysis of Hematopoietic Stem Cell Transplantation Market in Japan

Japan is expected to grow at 7.5% through 2036, supported by established transplant centres, cord blood banking infrastructure, and clinical research in transplant optimization.

  • Established transplant centres provide clinical expertise.
  • Cord blood banking supports alternative donor access.
  • Clinical research advances transplant approaches.

Sales Analysis of Hematopoietic Stem Cell Transplantation Market in the United Kingdom

The UK is expected to grow at 7.3% through 2036, supported by NHS transplant commissioning, Anthony Nolan donor registry, and BSBMT clinical standards.

  • NHS commissioning supports transplant programme funding.
  • Anthony Nolan registry provides donor matching.
  • Clinical standards guide transplant practice.

Opportunity Analysis of Hematopoietic Stem Cell Transplantation Market in the United States

The USA is expected to grow at 7.7% through 2036, driven by the highest transplant volume globally, NMDP/Be The Match donor registry, and advancing transplant research.

  • Highest global transplant volume sustains market scale.
  • NMDP donor registry provides extensive matching options.
  • Transplant research advances clinical protocols.

Competitive Landscape and Strategic Positioning

Hematopoietic Stem Cell Transplantation Market Analysis By Company

  • Pluristem Therapeutics Inc. leads with an estimated 20.1% market share.
  • The competitive landscape includes global and specialized players.
  • Entry barriers include regulatory, relationship, and scale factors.

Pluristem Therapeutics Inc. leads through its cell therapy and transplant support product portfolio addressing GVHD and engraftment complications.

CellGenix GmbH and Regen Biopharma Inc. maintain positions through transplant cell processing and supportive care products used in HSCT programmes.

Lonza Group and Sanofi compete on pharmaceutical manufacturing and supportive care product supply supporting conditioning regimens and post-transplant management.

Entry barriers include the specialized transplant medicine expertise, regulatory requirements for cell therapy products, and the established relationships between transplant centres and pharmaceutical suppliers.

Key Companies in the Hematopoietic Stem Cell Transplantation Market

Key global companies leading the hematopoietic stem cell transplantation market include:

  • Pluristem Therapeutics Inc. (Israel), CellGenix GmbH (Germany), and Lonza Group (Switzerland) hold leading positions through cell therapy products and transplant support portfolios.
  • Regen Biopharma Inc. (USA) and Sanofi (France) compete on transplant pharmaceuticals and supportive care products.
  • Miltenyi Biotec (Germany), Takara Bio (Japan), and STEMCELL Technologies (Canada) represent cell processing and transplant technology positions.

Competitive Benchmarking: Hematopoietic Stem Cell Transplantation Market

Company Cell Therapy Portfolio Transplant Support Products Manufacturing Scale Geographic Reach
Pluristem Therapeutics Inc. High Medium Medium Global
CellGenix GmbH Medium High Medium Europe, Global
Regen Biopharma Inc. Medium Medium Low N. America
Lonza Group Low Medium High Global
Sanofi Low High High Global
Miltenyi Biotec Medium High Medium Europe, Global

Source: Future Market Insights competitive analysis, 2026.

Key Developments in Hematopoietic Stem Cell Transplantation Market

  • In 2025, Miltenyi Biotec continued to enhance its cell processing and separation technologies supporting hematopoietic stem cell transplantation workflows, contributing to improved efficiency and standardization in allogeneic HSCT preparation across transplant centers.
  • In 2025, Pluristem Therapeutics Inc. continued clinical development of cell-based therapeutic approaches targeting complications associated with allogeneic hematopoietic stem cell transplantation, including graft-versus-host disease (GVHD), within broader regenerative medicine programs.

Key Players in the Hematopoietic Stem Cell Transplantation Market

Major Global Players

  • Pluristem Therapeutics Inc.
  • CellGenix GmbH
  • Regen Biopharma Inc.
  • Lonza Group
  • Sanofi
  • Taiga Biotechnologies, Inc.
  • Takeda Pharmaceutical Company Limited

Emerging Players/Startups

  • Miltenyi Biotec
  • Takara Bio
  • STEMCELL Technologies
  • Medipost
  • Mesoblast

Report Scope and Coverage

Hematopoietic Stem Cell Transplantation Market Breakdown By Transplant Type, Indication, And Region

Parameter Details
Quantitative Units USD 8.78 billion to USD 18.61 billion, at a CAGR of 7.8%
Market Definition The hematopoietic stem cell transplantation market covers clinical services, pharmaceutical products, and supportive care associated with bone marrow and stem cell transplantation procedures for hematological malignancies, bone marrow failure syndromes, and immune deficiency conditions. Services include donor matching, conditioning regimens, transplantation procedures, and post-transplant management.
Regions Covered North America, Latin America, Europe, East Asia, South Asia and Pacific, Middle East and Africa
Countries Covered USA, UK, France, Germany, Italy, South Korea, Japan, China, India, 30 plus countries
Key Companies Profiled Pluristem Therapeutics Inc., CellGenix GmbH, Regen Biopharma Inc., Lonza Group, Sanofi, Taiga Biotechnologies, Inc., Takeda Pharmaceutical Company Limited, Escape Therapeutics, Inc., Bluebird Bio, Talaris Therapeutics
Forecast Period 2026 to 2036
Approach Hybrid bottom-up and top-down methodology starting with verified transaction data, projecting adoption velocity across segments and regions.

Market Segmentation Analysis

Hematopoietic Stem Cell Transplantation Market Market Segmented by Transplant Type:

  • Allogeneic
  • Autologous

Hematopoietic Stem Cell Transplantation Market Market Segmented by Indication:

  • Acute Myeloid Leukemia
  • Acute Lymphoblastic Leukemia
  • Hodgkin Lymphoma
  • Non-Hodgkin Lymphoma
  • Multiple Myeloma
  • Other Non-Malignant Disorders

Hematopoietic Stem Cell Transplantation Market Market Segmented by Application:

  • Peripheral Blood Stem Cells Transplant
  • Bone Marrow Transplant
  • Cord Blood Transplant

Hematopoietic Stem Cell Transplantation Market Market Segmented by End User:

  • Transplant Centers
    • Academic Hospitals
    • General Hospitals
    • Specialty Clinics

Hematopoietic Stem Cell Transplantation Market Market by Region:

  • North America
    • USA
    • Canada
    • Mexico
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Western Europe
    • Germany
    • UK
    • Italy
    • Spain
    • France
    • Nordic
    • BENELUX
    • Rest of Western Europe
  • Eastern Europe
    • Russia
    • Poland
    • Hungary
    • Balkan & Baltic
    • Rest of Eastern Europe
  • East Asia
    • China
    • Japan
    • South Korea
  • South Asia and Pacific
    • India
    • ASEAN
    • Australia & New Zealand
    • Rest of South Asia and Pacific
  • Middle East & Africa
    • Kingdom of Saudi Arabia
    • Other GCC Countries
    • Turkiye
    • South Africa
    • Other African Union
    • Rest of Middle East & Africa

Research Sources and Bibliography

  • 1. Center for International Blood and Marrow Transplant Research. (2025). CIBMTR Annual Report: HSCT Activity and Outcomes. CIBMTR.
  • 2. European Society for Blood and Marrow Transplantation. (2024). EBMT Activity Survey: European Transplant Statistics. EBMT.
  • 3. National Marrow Donor Program. (2025). NMDP/Be The Match: Donor Registry and Transplant Activity Report. NMDP.
  • 4. World Marrow Donor Association. (2024). WMDA Annual Report: International Donor Registry Statistics. WMDA.
  • 5. World Health Organization. (2024). WHO Classification of Hematopoietic and Lymphoid Tumours. WHO.

This bibliography is provided for reader reference. The full Future Market Insights report contains the complete reference list with publication dates, URLs, and supporting data for all cited works.

This Report Answers

  • Estimating the market size and revenue from 2026 to 2036.
  • Segmentation by transplant type, indication, application, and end user.
  • Regional and country-level insights across more than 30 markets.
  • Donor registry and stem cell source analysis.
  • Competitive landscape assessment.
  • Investment opportunity identification.
  • Transplant outcome and clinical protocol analysis.
  • Data delivery in PDF and Excel formats.

Frequently Asked Questions

What is the global market demand for Hematopoietic Stem Cell Transplantation in 2026?

In 2026, the global market is expected to be worth USD 8.78 billion.

How big will the Hematopoietic Stem Cell Transplantation Market be in 2036?

By 2036, the market is expected to be worth USD 18.61 billion.

How much is demand expected to grow between 2026 and 2036?

Between 2026 and 2036, demand is expected to grow at a CAGR of 7.8%.

Which Transplant Type segment is expected to lead in 2026?

Allogeneic is expected to account for 57.3% of the segment in 2026.

What is causing demand to rise in South Korea?

South Korea is expected to grow at 8.0% through 2036.

What is causing demand to rise in EU?

EU is expected to grow at 7.9% through 2036.

What does this report mean by Hematopoietic Stem Cell Transplantation Market definition?

The hematopoietic stem cell transplantation market covers clinical services, pharmaceutical products, and supportive care associated with bone marrow and stem cell transplantation procedures for hemat.

How does FMI make the forecast?

Forecasting uses a hybrid bottom-up and top-down methodology starting with verified transaction data, projecting adoption velocity across segments and regions.

Table of Content

  1. Executive Summary
    • Global Market Outlook
    • Demand to side Trends
    • Supply to side Trends
    • Technology Roadmap Analysis
    • Analysis and Recommendations
  2. Market Overview
    • Market Coverage / Taxonomy
    • Market Definition / Scope / Limitations
  3. Research Methodology
    • Chapter Orientation
    • Analytical Lens and Working Hypotheses
      • Market Structure, Signals, and Trend Drivers
      • Benchmarking and Cross-market Comparability
      • Market Sizing, Forecasting, and Opportunity Mapping
    • Research Design and Evidence Framework
      • Desk Research Programme (Secondary Evidence)
        • Company Annual and Sustainability Reports
        • Peer-reviewed Journals and Academic Literature
        • Corporate Websites, Product Literature, and Technical Notes
        • Earnings Decks and Investor Briefings
        • Statutory Filings and Regulatory Disclosures
        • Technical White Papers and Standards Notes
        • Trade Journals, Industry Magazines, and Analyst Briefs
        • Conference Proceedings, Webinars, and Seminar Materials
        • Government Statistics Portals and Public Data Releases
        • Press Releases and Reputable Media Coverage
        • Specialist Newsletters and Curated Briefings
        • Sector Databases and Reference Repositories
        • FMI Internal Proprietary Databases and Historical Market Datasets
        • Subscription Datasets and Paid Sources
        • Social Channels, Communities, and Digital Listening Inputs
        • Additional Desk Sources
      • Expert Input and Fieldwork (Primary Evidence)
        • Primary Modes
          • Qualitative Interviews and Expert Elicitation
          • Quantitative Surveys and Structured Data Capture
          • Blended Approach
        • Why Primary Evidence is Used
        • Field Techniques
          • Interviews
          • Surveys
          • Focus Groups
          • Observational and In-context Research
          • Social and Community Interactions
        • Stakeholder Universe Engaged
          • C-suite Leaders
          • Board Members
          • Presidents and Vice Presidents
          • R&D and Innovation Heads
          • Technical Specialists
          • Domain Subject-matter Experts
          • Scientists
          • Physicians and Other Healthcare Professionals
        • Governance, Ethics, and Data Stewardship
          • Research Ethics
          • Data Integrity and Handling
      • Tooling, Models, and Reference Databases
    • Data Engineering and Model Build
      • Data Acquisition and Ingestion
      • Cleaning, Normalisation, and Verification
      • Synthesis, Triangulation, and Analysis
    • Quality Assurance and Audit Trail
  4. Market Background
    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunity
      • Trends
    • Scenario Forecast
      • Demand in Optimistic Scenario
      • Demand in Likely Scenario
      • Demand in Conservative Scenario
    • Opportunity Map Analysis
    • Product Life Cycle Analysis
    • Supply Chain Analysis
    • Investment Feasibility Matrix
    • Value Chain Analysis
    • PESTLE and Porter’s Analysis
    • Regulatory Landscape
    • Regional Parent Market Outlook
    • Production and Consumption Statistics
    • Import and Export Statistics
  5. Global Market Analysis 2021 to 2025 and Forecast, 2026 to 2036
    • Historical Market Size Value (USD Million) Analysis, 2021 to 2025
    • Current and Future Market Size Value (USD Million) Projections, 2026 to 2036
      • Y to o to Y Growth Trend Analysis
      • Absolute $ Opportunity Analysis
  6. Global Market Pricing Analysis 2021 to 2025 and Forecast 2026 to 2036
  7. Global Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Transplant Type
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By Transplant Type , 2021 to 2025
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By Transplant Type , 2026 to 2036
      • Allogeneic
      • Autologous
    • Y to o to Y Growth Trend Analysis By Transplant Type , 2021 to 2025
    • Absolute $ Opportunity Analysis By Transplant Type , 2026 to 2036
  8. Global Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Indication
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By Indication, 2021 to 2025
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By Indication, 2026 to 2036
      • Acute Myeloid Leukemia
      • Acute Lymphoblastic Leukemia
      • Hodgkin Lymphoma
      • Non-Hodgkin Lymphoma
      • Multiple Myeloma
      • Other Non-Malignant Disorders
    • Y to o to Y Growth Trend Analysis By Indication, 2021 to 2025
    • Absolute $ Opportunity Analysis By Indication, 2026 to 2036
  9. Global Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Application
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By Application, 2021 to 2025
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By Application, 2026 to 2036
      • Peripheral Blood Stem Cells Transplant
      • Bone Marrow Transplant
      • Cord Blood Transplant
    • Y to o to Y Growth Trend Analysis By Application, 2021 to 2025
    • Absolute $ Opportunity Analysis By Application, 2026 to 2036
  10. Global Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By End User
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By End User, 2021 to 2025
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By End User, 2026 to 2036
      • Transplant Centers
        • Academic Hospitals
        • General Hospitals
        • Specialty Clinics
    • Y to o to Y Growth Trend Analysis By End User, 2021 to 2025
    • Absolute $ Opportunity Analysis By End User, 2026 to 2036
  11. Global Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Region
    • Introduction
    • Historical Market Size Value (USD Million) Analysis By Region, 2021 to 2025
    • Current Market Size Value (USD Million) Analysis and Forecast By Region, 2026 to 2036
      • North America
      • Latin America
      • Western Europe
      • Eastern Europe
      • East Asia
      • South Asia and Pacific
      • Middle East & Africa
    • Market Attractiveness Analysis By Region
  12. North America Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
        • USA
        • Canada
        • Mexico
      • By Transplant Type
      • By Indication
      • By Application
      • By End User
    • Market Attractiveness Analysis
      • By Country
      • By Transplant Type
      • By Indication
      • By Application
      • By End User
    • Key Takeaways
  13. Latin America Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
        • Brazil
        • Chile
        • Rest of Latin America
      • By Transplant Type
      • By Indication
      • By Application
      • By End User
    • Market Attractiveness Analysis
      • By Country
      • By Transplant Type
      • By Indication
      • By Application
      • By End User
    • Key Takeaways
  14. Western Europe Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
        • Germany
        • UK
        • Italy
        • Spain
        • France
        • Nordic
        • BENELUX
        • Rest of Western Europe
      • By Transplant Type
      • By Indication
      • By Application
      • By End User
    • Market Attractiveness Analysis
      • By Country
      • By Transplant Type
      • By Indication
      • By Application
      • By End User
    • Key Takeaways
  15. Eastern Europe Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
        • Russia
        • Poland
        • Hungary
        • Balkan & Baltic
        • Rest of Eastern Europe
      • By Transplant Type
      • By Indication
      • By Application
      • By End User
    • Market Attractiveness Analysis
      • By Country
      • By Transplant Type
      • By Indication
      • By Application
      • By End User
    • Key Takeaways
  16. East Asia Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
        • China
        • Japan
        • South Korea
      • By Transplant Type
      • By Indication
      • By Application
      • By End User
    • Market Attractiveness Analysis
      • By Country
      • By Transplant Type
      • By Indication
      • By Application
      • By End User
    • Key Takeaways
  17. South Asia and Pacific Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
        • India
        • ASEAN
        • Australia & New Zealand
        • Rest of South Asia and Pacific
      • By Transplant Type
      • By Indication
      • By Application
      • By End User
    • Market Attractiveness Analysis
      • By Country
      • By Transplant Type
      • By Indication
      • By Application
      • By End User
    • Key Takeaways
  18. Middle East & Africa Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
        • Kingdom of Saudi Arabia
        • Other GCC Countries
        • Turkiye
        • South Africa
        • Other African Union
        • Rest of Middle East & Africa
      • By Transplant Type
      • By Indication
      • By Application
      • By End User
    • Market Attractiveness Analysis
      • By Country
      • By Transplant Type
      • By Indication
      • By Application
      • By End User
    • Key Takeaways
  19. Key Countries Market Analysis
    • USA
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Transplant Type
        • By Indication
        • By Application
        • By End User
    • Canada
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Transplant Type
        • By Indication
        • By Application
        • By End User
    • Mexico
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Transplant Type
        • By Indication
        • By Application
        • By End User
    • Brazil
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Transplant Type
        • By Indication
        • By Application
        • By End User
    • Chile
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Transplant Type
        • By Indication
        • By Application
        • By End User
    • Germany
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Transplant Type
        • By Indication
        • By Application
        • By End User
    • UK
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Transplant Type
        • By Indication
        • By Application
        • By End User
    • Italy
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Transplant Type
        • By Indication
        • By Application
        • By End User
    • Spain
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Transplant Type
        • By Indication
        • By Application
        • By End User
    • France
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Transplant Type
        • By Indication
        • By Application
        • By End User
    • India
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Transplant Type
        • By Indication
        • By Application
        • By End User
    • ASEAN
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Transplant Type
        • By Indication
        • By Application
        • By End User
    • Australia & New Zealand
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Transplant Type
        • By Indication
        • By Application
        • By End User
    • China
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Transplant Type
        • By Indication
        • By Application
        • By End User
    • Japan
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Transplant Type
        • By Indication
        • By Application
        • By End User
    • South Korea
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Transplant Type
        • By Indication
        • By Application
        • By End User
    • Russia
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Transplant Type
        • By Indication
        • By Application
        • By End User
    • Poland
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Transplant Type
        • By Indication
        • By Application
        • By End User
    • Hungary
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Transplant Type
        • By Indication
        • By Application
        • By End User
    • Kingdom of Saudi Arabia
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Transplant Type
        • By Indication
        • By Application
        • By End User
    • Turkiye
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Transplant Type
        • By Indication
        • By Application
        • By End User
    • South Africa
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Transplant Type
        • By Indication
        • By Application
        • By End User
  20. Market Structure Analysis
    • Competition Dashboard
    • Competition Benchmarking
    • Market Share Analysis of Top Players
      • By Regional
      • By Transplant Type
      • By Indication
      • By Application
      • By End User
  21. Competition Analysis
    • Competition Deep Dive
      • Pluristem Therapeutics Inc.
        • Overview
        • Product Portfolio
        • Profitability by Market Segments (Product/Age /Sales Channel/Region)
        • Sales Footprint
        • Strategy Overview
          • Marketing Strategy
          • Product Strategy
          • Channel Strategy
      • CellGenix GmbH
      • Regen Biopharma Inc.
      • Lonza Group
      • Sanofi
      • Taiga Biotechnologies, Inc.
      • Takeda Pharmaceutical Company Limited
      • Escape Therapeutics, Inc.
      • Bluebird Bio
      • Talaris Therapeutics
  22. Assumptions & Acronyms Used

List of Tables

  • Table 1: Global Market Value (USD Million) Forecast by Region, 2021 to 2036
  • Table 2: Global Market Value (USD Million) Forecast by Transplant Type , 2021 to 2036
  • Table 3: Global Market Value (USD Million) Forecast by Indication, 2021 to 2036
  • Table 4: Global Market Value (USD Million) Forecast by Application, 2021 to 2036
  • Table 5: Global Market Value (USD Million) Forecast by End User, 2021 to 2036
  • Table 6: North America Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 7: North America Market Value (USD Million) Forecast by Transplant Type , 2021 to 2036
  • Table 8: North America Market Value (USD Million) Forecast by Indication, 2021 to 2036
  • Table 9: North America Market Value (USD Million) Forecast by Application, 2021 to 2036
  • Table 10: North America Market Value (USD Million) Forecast by End User, 2021 to 2036
  • Table 11: Latin America Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 12: Latin America Market Value (USD Million) Forecast by Transplant Type , 2021 to 2036
  • Table 13: Latin America Market Value (USD Million) Forecast by Indication, 2021 to 2036
  • Table 14: Latin America Market Value (USD Million) Forecast by Application, 2021 to 2036
  • Table 15: Latin America Market Value (USD Million) Forecast by End User, 2021 to 2036
  • Table 16: Western Europe Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 17: Western Europe Market Value (USD Million) Forecast by Transplant Type , 2021 to 2036
  • Table 18: Western Europe Market Value (USD Million) Forecast by Indication, 2021 to 2036
  • Table 19: Western Europe Market Value (USD Million) Forecast by Application, 2021 to 2036
  • Table 20: Western Europe Market Value (USD Million) Forecast by End User, 2021 to 2036
  • Table 21: Eastern Europe Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 22: Eastern Europe Market Value (USD Million) Forecast by Transplant Type , 2021 to 2036
  • Table 23: Eastern Europe Market Value (USD Million) Forecast by Indication, 2021 to 2036
  • Table 24: Eastern Europe Market Value (USD Million) Forecast by Application, 2021 to 2036
  • Table 25: Eastern Europe Market Value (USD Million) Forecast by End User, 2021 to 2036
  • Table 26: East Asia Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 27: East Asia Market Value (USD Million) Forecast by Transplant Type , 2021 to 2036
  • Table 28: East Asia Market Value (USD Million) Forecast by Indication, 2021 to 2036
  • Table 29: East Asia Market Value (USD Million) Forecast by Application, 2021 to 2036
  • Table 30: East Asia Market Value (USD Million) Forecast by End User, 2021 to 2036
  • Table 31: South Asia and Pacific Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 32: South Asia and Pacific Market Value (USD Million) Forecast by Transplant Type , 2021 to 2036
  • Table 33: South Asia and Pacific Market Value (USD Million) Forecast by Indication, 2021 to 2036
  • Table 34: South Asia and Pacific Market Value (USD Million) Forecast by Application, 2021 to 2036
  • Table 35: South Asia and Pacific Market Value (USD Million) Forecast by End User, 2021 to 2036
  • Table 36: Middle East & Africa Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 37: Middle East & Africa Market Value (USD Million) Forecast by Transplant Type , 2021 to 2036
  • Table 38: Middle East & Africa Market Value (USD Million) Forecast by Indication, 2021 to 2036
  • Table 39: Middle East & Africa Market Value (USD Million) Forecast by Application, 2021 to 2036
  • Table 40: Middle East & Africa Market Value (USD Million) Forecast by End User, 2021 to 2036

List of Figures

  • Figure 1: Global Market Pricing Analysis
  • Figure 2: Global Market Value (USD Million) Forecast 2021-2036
  • Figure 3: Global Market Value Share and BPS Analysis by Transplant Type , 2026 and 2036
  • Figure 4: Global Market Y-o-Y Growth Comparison by Transplant Type , 2026-2036
  • Figure 5: Global Market Attractiveness Analysis by Transplant Type
  • Figure 6: Global Market Value Share and BPS Analysis by Indication, 2026 and 2036
  • Figure 7: Global Market Y-o-Y Growth Comparison by Indication, 2026-2036
  • Figure 8: Global Market Attractiveness Analysis by Indication
  • Figure 9: Global Market Value Share and BPS Analysis by Application, 2026 and 2036
  • Figure 10: Global Market Y-o-Y Growth Comparison by Application, 2026-2036
  • Figure 11: Global Market Attractiveness Analysis by Application
  • Figure 12: Global Market Value Share and BPS Analysis by End User, 2026 and 2036
  • Figure 13: Global Market Y-o-Y Growth Comparison by End User, 2026-2036
  • Figure 14: Global Market Attractiveness Analysis by End User
  • Figure 15: Global Market Value (USD Million) Share and BPS Analysis by Region, 2026 and 2036
  • Figure 16: Global Market Y-o-Y Growth Comparison by Region, 2026-2036
  • Figure 17: Global Market Attractiveness Analysis by Region
  • Figure 18: North America Market Incremental Dollar Opportunity, 2026-2036
  • Figure 19: Latin America Market Incremental Dollar Opportunity, 2026-2036
  • Figure 20: Western Europe Market Incremental Dollar Opportunity, 2026-2036
  • Figure 21: Eastern Europe Market Incremental Dollar Opportunity, 2026-2036
  • Figure 22: East Asia Market Incremental Dollar Opportunity, 2026-2036
  • Figure 23: South Asia and Pacific Market Incremental Dollar Opportunity, 2026-2036
  • Figure 24: Middle East & Africa Market Incremental Dollar Opportunity, 2026-2036
  • Figure 25: North America Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 26: North America Market Value Share and BPS Analysis by Transplant Type , 2026 and 2036
  • Figure 27: North America Market Y-o-Y Growth Comparison by Transplant Type , 2026-2036
  • Figure 28: North America Market Attractiveness Analysis by Transplant Type
  • Figure 29: North America Market Value Share and BPS Analysis by Indication, 2026 and 2036
  • Figure 30: North America Market Y-o-Y Growth Comparison by Indication, 2026-2036
  • Figure 31: North America Market Attractiveness Analysis by Indication
  • Figure 32: North America Market Value Share and BPS Analysis by Application, 2026 and 2036
  • Figure 33: North America Market Y-o-Y Growth Comparison by Application, 2026-2036
  • Figure 34: North America Market Attractiveness Analysis by Application
  • Figure 35: North America Market Value Share and BPS Analysis by End User, 2026 and 2036
  • Figure 36: North America Market Y-o-Y Growth Comparison by End User, 2026-2036
  • Figure 37: North America Market Attractiveness Analysis by End User
  • Figure 38: Latin America Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 39: Latin America Market Value Share and BPS Analysis by Transplant Type , 2026 and 2036
  • Figure 40: Latin America Market Y-o-Y Growth Comparison by Transplant Type , 2026-2036
  • Figure 41: Latin America Market Attractiveness Analysis by Transplant Type
  • Figure 42: Latin America Market Value Share and BPS Analysis by Indication, 2026 and 2036
  • Figure 43: Latin America Market Y-o-Y Growth Comparison by Indication, 2026-2036
  • Figure 44: Latin America Market Attractiveness Analysis by Indication
  • Figure 45: Latin America Market Value Share and BPS Analysis by Application, 2026 and 2036
  • Figure 46: Latin America Market Y-o-Y Growth Comparison by Application, 2026-2036
  • Figure 47: Latin America Market Attractiveness Analysis by Application
  • Figure 48: Latin America Market Value Share and BPS Analysis by End User, 2026 and 2036
  • Figure 49: Latin America Market Y-o-Y Growth Comparison by End User, 2026-2036
  • Figure 50: Latin America Market Attractiveness Analysis by End User
  • Figure 51: Western Europe Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 52: Western Europe Market Value Share and BPS Analysis by Transplant Type , 2026 and 2036
  • Figure 53: Western Europe Market Y-o-Y Growth Comparison by Transplant Type , 2026-2036
  • Figure 54: Western Europe Market Attractiveness Analysis by Transplant Type
  • Figure 55: Western Europe Market Value Share and BPS Analysis by Indication, 2026 and 2036
  • Figure 56: Western Europe Market Y-o-Y Growth Comparison by Indication, 2026-2036
  • Figure 57: Western Europe Market Attractiveness Analysis by Indication
  • Figure 58: Western Europe Market Value Share and BPS Analysis by Application, 2026 and 2036
  • Figure 59: Western Europe Market Y-o-Y Growth Comparison by Application, 2026-2036
  • Figure 60: Western Europe Market Attractiveness Analysis by Application
  • Figure 61: Western Europe Market Value Share and BPS Analysis by End User, 2026 and 2036
  • Figure 62: Western Europe Market Y-o-Y Growth Comparison by End User, 2026-2036
  • Figure 63: Western Europe Market Attractiveness Analysis by End User
  • Figure 64: Eastern Europe Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 65: Eastern Europe Market Value Share and BPS Analysis by Transplant Type , 2026 and 2036
  • Figure 66: Eastern Europe Market Y-o-Y Growth Comparison by Transplant Type , 2026-2036
  • Figure 67: Eastern Europe Market Attractiveness Analysis by Transplant Type
  • Figure 68: Eastern Europe Market Value Share and BPS Analysis by Indication, 2026 and 2036
  • Figure 69: Eastern Europe Market Y-o-Y Growth Comparison by Indication, 2026-2036
  • Figure 70: Eastern Europe Market Attractiveness Analysis by Indication
  • Figure 71: Eastern Europe Market Value Share and BPS Analysis by Application, 2026 and 2036
  • Figure 72: Eastern Europe Market Y-o-Y Growth Comparison by Application, 2026-2036
  • Figure 73: Eastern Europe Market Attractiveness Analysis by Application
  • Figure 74: Eastern Europe Market Value Share and BPS Analysis by End User, 2026 and 2036
  • Figure 75: Eastern Europe Market Y-o-Y Growth Comparison by End User, 2026-2036
  • Figure 76: Eastern Europe Market Attractiveness Analysis by End User
  • Figure 77: East Asia Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 78: East Asia Market Value Share and BPS Analysis by Transplant Type , 2026 and 2036
  • Figure 79: East Asia Market Y-o-Y Growth Comparison by Transplant Type , 2026-2036
  • Figure 80: East Asia Market Attractiveness Analysis by Transplant Type
  • Figure 81: East Asia Market Value Share and BPS Analysis by Indication, 2026 and 2036
  • Figure 82: East Asia Market Y-o-Y Growth Comparison by Indication, 2026-2036
  • Figure 83: East Asia Market Attractiveness Analysis by Indication
  • Figure 84: East Asia Market Value Share and BPS Analysis by Application, 2026 and 2036
  • Figure 85: East Asia Market Y-o-Y Growth Comparison by Application, 2026-2036
  • Figure 86: East Asia Market Attractiveness Analysis by Application
  • Figure 87: East Asia Market Value Share and BPS Analysis by End User, 2026 and 2036
  • Figure 88: East Asia Market Y-o-Y Growth Comparison by End User, 2026-2036
  • Figure 89: East Asia Market Attractiveness Analysis by End User
  • Figure 90: South Asia and Pacific Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 91: South Asia and Pacific Market Value Share and BPS Analysis by Transplant Type , 2026 and 2036
  • Figure 92: South Asia and Pacific Market Y-o-Y Growth Comparison by Transplant Type , 2026-2036
  • Figure 93: South Asia and Pacific Market Attractiveness Analysis by Transplant Type
  • Figure 94: South Asia and Pacific Market Value Share and BPS Analysis by Indication, 2026 and 2036
  • Figure 95: South Asia and Pacific Market Y-o-Y Growth Comparison by Indication, 2026-2036
  • Figure 96: South Asia and Pacific Market Attractiveness Analysis by Indication
  • Figure 97: South Asia and Pacific Market Value Share and BPS Analysis by Application, 2026 and 2036
  • Figure 98: South Asia and Pacific Market Y-o-Y Growth Comparison by Application, 2026-2036
  • Figure 99: South Asia and Pacific Market Attractiveness Analysis by Application
  • Figure 100: South Asia and Pacific Market Value Share and BPS Analysis by End User, 2026 and 2036
  • Figure 101: South Asia and Pacific Market Y-o-Y Growth Comparison by End User, 2026-2036
  • Figure 102: South Asia and Pacific Market Attractiveness Analysis by End User
  • Figure 103: Middle East & Africa Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 104: Middle East & Africa Market Value Share and BPS Analysis by Transplant Type , 2026 and 2036
  • Figure 105: Middle East & Africa Market Y-o-Y Growth Comparison by Transplant Type , 2026-2036
  • Figure 106: Middle East & Africa Market Attractiveness Analysis by Transplant Type
  • Figure 107: Middle East & Africa Market Value Share and BPS Analysis by Indication, 2026 and 2036
  • Figure 108: Middle East & Africa Market Y-o-Y Growth Comparison by Indication, 2026-2036
  • Figure 109: Middle East & Africa Market Attractiveness Analysis by Indication
  • Figure 110: Middle East & Africa Market Value Share and BPS Analysis by Application, 2026 and 2036
  • Figure 111: Middle East & Africa Market Y-o-Y Growth Comparison by Application, 2026-2036
  • Figure 112: Middle East & Africa Market Attractiveness Analysis by Application
  • Figure 113: Middle East & Africa Market Value Share and BPS Analysis by End User, 2026 and 2036
  • Figure 114: Middle East & Africa Market Y-o-Y Growth Comparison by End User, 2026-2036
  • Figure 115: Middle East & Africa Market Attractiveness Analysis by End User
  • Figure 116: Global Market - Tier Structure Analysis
  • Figure 117: Global Market - Company Share Analysis

Full Research Suite comprises of:

Market outlook & trends analysis

Market outlook & trends analysis

Interviews & case studies

Interviews & case studies

Strategic recommendations

Strategic recommendations

Vendor profiles & capabilities analysis

Vendor profiles & capabilities analysis

5-year forecasts

5-year forecasts

8 regions and 60+ country-level data splits

8 regions and 60+ country-level data splits

Market segment data splits

Market segment data splits

12 months of continuous data updates

12 months of continuous data updates

DELIVERED AS:

PDF EXCEL ONLINE

Free Sample Report Download PDF

Full Research Suite

$5000

$7500

$10000

Buy Report Now